The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Metabolic Biomarker Testing Market Research Report 2024

Global Metabolic Biomarker Testing Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1805778

No of Pages : 81

In medicine, a biomarker is a measurable indicator of the severity or presence of some disease state. More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism.

Global Metabolic Biomarker Testing market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Metabolic Biomarker Testing market research.

Biomarkers are useful in a number of ways, including measuring the progress of disease, evaluating the most effective therapeutic regimes for a particular cancer type, and establishing long-term susceptibility to cancer or its recurrence. The parameter can be chemical, physical or biological. Biomarkers help in early diagnosis, disease prevention, drug target identification, drug response etc. Several biomarkers have been identified for many diseases such as serum LDL for cholesterol, blood pressure, and P53 gene[4]and MMPs [5] as tumor markers for cancer. Biomarkers are also seen as the key to personalised medicine, treatments individually tailored to specific patients for highly efficient intervention in disease processes. Often, such biomarkers indicate changes in metabolic processes.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Metabolic Biomarker Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Agilent Technologies
  •     Bio-Rad Laboratories
  •     Bruker
  •     Danaher
  •     Waters Corporation
  •     Thermo Fisher Scientific
  •     Biocrates Life Sciences
  •     Human Metabolome Technologies

Segment by Technology

  •     Separation Techniques
  •     Detection Techniques
  •     Others

Segment by Application

  •     Drug Discovery
  •     Nutrigenomics
  •     Toxicology Testing
  •     Personalized Medicine
  •     Functional Genomics
  •     Others

By Region

  •     North America (United States, Canada)
  •     Europe (Germany, France, U.K., Italy, Russia)
  •     Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  •     Latin America (Mexico, Brazil, Argentina)
  •     Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Metabolic Biomarker Testing report covers below items:

Chapter 1: Product Basic Information (Definition, Technology and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Technology Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Technology
        1.2.1 Global Metabolic Biomarker Testing Market Size Growth Rate by Technology: 2018 VS 2022 VS 2029
        1.2.2 Separation Techniques
        1.2.3 Detection Techniques
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Metabolic Biomarker Testing Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Drug Discovery
        1.3.3 Nutrigenomics
        1.3.4 Toxicology Testing
        1.3.5 Personalized Medicine
        1.3.6 Functional Genomics
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Metabolic Biomarker Testing Market Perspective (2018-2029)
    2.2 Metabolic Biomarker Testing Growth Trends by Region
        2.2.1 Global Metabolic Biomarker Testing Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Metabolic Biomarker Testing Historic Market Size by Region (2018-2023)
        2.2.3 Metabolic Biomarker Testing Forecasted Market Size by Region (2024-2029)
    2.3 Metabolic Biomarker Testing Market Dynamics
        2.3.1 Metabolic Biomarker Testing Industry Trends
        2.3.2 Metabolic Biomarker Testing Market Drivers
        2.3.3 Metabolic Biomarker Testing Market Challenges
        2.3.4 Metabolic Biomarker Testing Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Metabolic Biomarker Testing Players by Revenue
        3.1.1 Global Top Metabolic Biomarker Testing Players by Revenue (2018-2023)
        3.1.2 Global Metabolic Biomarker Testing Revenue Market Share by Players (2018-2023)
    3.2 Global Metabolic Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Metabolic Biomarker Testing Revenue
    3.4 Global Metabolic Biomarker Testing Market Concentration Ratio
        3.4.1 Global Metabolic Biomarker Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Metabolic Biomarker Testing Revenue in 2022
    3.5 Metabolic Biomarker Testing Key Players Head office and Area Served
    3.6 Key Players Metabolic Biomarker Testing Product Solution and Service
    3.7 Date of Enter into Metabolic Biomarker Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Metabolic Biomarker Testing Breakdown Data by Technology
    4.1 Global Metabolic Biomarker Testing Historic Market Size by Technology (2018-2023)
    4.2 Global Metabolic Biomarker Testing Forecasted Market Size by Technology (2024-2029)

 5 Metabolic Biomarker Testing Breakdown Data by Application
    5.1 Global Metabolic Biomarker Testing Historic Market Size by Application (2018-2023)
    5.2 Global Metabolic Biomarker Testing Forecasted Market Size by Application (2024-2029)

 6 North America
    6.1 North America Metabolic Biomarker Testing Market Size (2018-2029)
    6.2 North America Metabolic Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Metabolic Biomarker Testing Market Size by Country (2018-2023)
    6.4 North America Metabolic Biomarker Testing Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Metabolic Biomarker Testing Market Size (2018-2029)
    7.2 Europe Metabolic Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Metabolic Biomarker Testing Market Size by Country (2018-2023)
    7.4 Europe Metabolic Biomarker Testing Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Metabolic Biomarker Testing Market Size (2018-2029)
    8.2 Asia-Pacific Metabolic Biomarker Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2018-2023)
    8.4 Asia-Pacific Metabolic Biomarker Testing Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Metabolic Biomarker Testing Market Size (2018-2029)
    9.2 Latin America Metabolic Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Metabolic Biomarker Testing Market Size by Country (2018-2023)
    9.4 Latin America Metabolic Biomarker Testing Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Metabolic Biomarker Testing Market Size (2018-2029)
    10.2 Middle East & Africa Metabolic Biomarker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2018-2023)
    10.4 Middle East & Africa Metabolic Biomarker Testing Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Agilent Technologies
        11.1.1 Agilent Technologies Company Detail
        11.1.2 Agilent Technologies Business Overview
        11.1.3 Agilent Technologies Metabolic Biomarker Testing Introduction
        11.1.4 Agilent Technologies Revenue in Metabolic Biomarker Testing Business (2018-2023)
        11.1.5 Agilent Technologies Recent Development
    11.2 Bio-Rad Laboratories
        11.2.1 Bio-Rad Laboratories Company Detail
        11.2.2 Bio-Rad Laboratories Business Overview
        11.2.3 Bio-Rad Laboratories Metabolic Biomarker Testing Introduction
        11.2.4 Bio-Rad Laboratories Revenue in Metabolic Biomarker Testing Business (2018-2023)
        11.2.5 Bio-Rad Laboratories Recent Development
    11.3 Bruker
        11.3.1 Bruker Company Detail
        11.3.2 Bruker Business Overview
        11.3.3 Bruker Metabolic Biomarker Testing Introduction
        11.3.4 Bruker Revenue in Metabolic Biomarker Testing Business (2018-2023)
        11.3.5 Bruker Recent Development
    11.4 Danaher
        11.4.1 Danaher Company Detail
        11.4.2 Danaher Business Overview
        11.4.3 Danaher Metabolic Biomarker Testing Introduction
        11.4.4 Danaher Revenue in Metabolic Biomarker Testing Business (2018-2023)
        11.4.5 Danaher Recent Development
    11.5 Waters Corporation
        11.5.1 Waters Corporation Company Detail
        11.5.2 Waters Corporation Business Overview
        11.5.3 Waters Corporation Metabolic Biomarker Testing Introduction
        11.5.4 Waters Corporation Revenue in Metabolic Biomarker Testing Business (2018-2023)
        11.5.5 Waters Corporation Recent Development
    11.6 Thermo Fisher Scientific
        11.6.1 Thermo Fisher Scientific Company Detail
        11.6.2 Thermo Fisher Scientific Business Overview
        11.6.3 Thermo Fisher Scientific Metabolic Biomarker Testing Introduction
        11.6.4 Thermo Fisher Scientific Revenue in Metabolic Biomarker Testing Business (2018-2023)
        11.6.5 Thermo Fisher Scientific Recent Development
    11.7 Biocrates Life Sciences
        11.7.1 Biocrates Life Sciences Company Detail
        11.7.2 Biocrates Life Sciences Business Overview
        11.7.3 Biocrates Life Sciences Metabolic Biomarker Testing Introduction
        11.7.4 Biocrates Life Sciences Revenue in Metabolic Biomarker Testing Business (2018-2023)
        11.7.5 Biocrates Life Sciences Recent Development
    11.8 Human Metabolome Technologies
        11.8.1 Human Metabolome Technologies Company Detail
        11.8.2 Human Metabolome Technologies Business Overview
        11.8.3 Human Metabolome Technologies Metabolic Biomarker Testing Introduction
        11.8.4 Human Metabolome Technologies Revenue in Metabolic Biomarker Testing Business (2018-2023)
        11.8.5 Human Metabolome Technologies Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’